Bergua Burgués, Juan Miguel | Hematología y Hemoterapia |

Resultados: 236
Tipo Título / Nombre Autor(es) Año
Pethema NGS-AML Project. Final Analysis and Clinical Validation of New Genomic Classifications Sargas C, Ayala R, Larryoz MJ..., Bergua J 2022
Evolution of the Genetic and Biological Studies Performed at Diagnosis in Patients with Acute Myeloid Leukemia Included in the Pethema Epidemiological Registry (REALMOL Study) Labrador J, Martinez-Cuadron D, Boluda B..., Bergua J 2022
The transcriptomic landscape of elderly acute myeloid leukemia identifies B7H3 and BANP as a favorable signature in high-risk patients Villar S, Ariceta B, Agirre X, Urribarri AD, Ayala R..., Bergua JM 2022
Impact of FLT3-ITD Mutation Status and Its Ratio in a Cohort of 2901 Patients Undergoing Upfront Intensive Chemotherapy: A PETHEMA Registry Study Ayala R, Carreño-Tarragona G, Barragán E, Boluda B, Larráyoz MJ..., Bergua J 2022
Polatuzumab Vedotin plus Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (Pola-R-CHP) versus Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (R-CHOP) therapy in patients with previously untreated Diffuse Large B-Cell Lymphoma (DLBCL): results from the phase III Polarix study Flowers C, Tilly H, Morschhauser F, Sehn LH, Friedberg JW..., Bergua-Burgués JM 2022
A scoring system for AML patients aged 70 years or older, eligible for intensive chemotherapy: a study based on a large European data set using the DATAML, SAL, and PETHEMA registries Bérard E, Röllig C, Bertoli S, Pigneux A, Tavitian S..., Bergua J 2022
Impact of Center-related Characteristics and Macroeconomic Factors on the Outcome of Adult Patients With Acute Lymphoblastic Leukemia Treated With Pediatric-inspired Protocols Barba P, Morgades M, Montesinos P, Gonzalez-Campos J, Torrent A..., Bergua J 2022
Pharmacokinetics and Pharmacodynamics in First-MIND: A Phase Ib, Open-Label, Randomized Study of Tafasitamab ± Lenalidomide + R-CHOP in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma Belada D, Kopeckova K, Bergua Burgués J, Stevens D, Nowakowski G, Waldron-Lynch M 2022
Midostaurin Maintenance versus Allo SCT versus W&W in FLT3-Mutated AML: A “Real-Life” Multicenter Study Fuente A de la, Díaz Beya M, Beneit P, Fernández Moreno A, Arnan Sangerman M..., Bergua J 2022
Impact of center characteristics and macroeconimic factors on the outcome of adult patients with acute lymphoblastic leukemia treated with peiatric-inspired protocols Barba P, Morgades M, Montesinos P, González Campos J..., Bergua Burgues J 2022